Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2018 19 October 2018NewsHumanBiosimilarsMedicinesRare diseasesReferralsVaccines New medicine for hereditary angioedema, a rare disease causing swelling beneath the skin 19 October 2018Press releaseHumanMedicinesRare diseases First treatment for rare inherited muscle contraction disorders 19 October 2018Press releaseHumanMedicinesRare diseases First vaccine for prevention of dengue 19 October 2018Press releaseHumanMedicines Regulatory information – adjusted fees for pharmacovigilance applications from 18 October 2018 18 October 2018NewsHumanCorporateFeesPharmacovigilance Shaping regulatory science to 2025 17 October 2018NewsHumanCorporateInnovationResearch and development Sales of antibiotics for use in food-producing animals drop across the EU 15 October 2018NewsVeterinaryAntimicrobial resistance EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU 15 October 2018Press releaseHumanReferrals Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2018 12 October 2018Press releaseVeterinaryMedicines Update on EMA’s Brexit preparedness 9 October 2018Press releaseHumanVeterinaryCorporateBrexit 1 … 109 110 111 112 113 Page 113 of 380 114 115 116 117 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2018 19 October 2018NewsHumanBiosimilarsMedicinesRare diseasesReferralsVaccines
New medicine for hereditary angioedema, a rare disease causing swelling beneath the skin 19 October 2018Press releaseHumanMedicinesRare diseases
First treatment for rare inherited muscle contraction disorders 19 October 2018Press releaseHumanMedicinesRare diseases
Regulatory information – adjusted fees for pharmacovigilance applications from 18 October 2018 18 October 2018NewsHumanCorporateFeesPharmacovigilance
Shaping regulatory science to 2025 17 October 2018NewsHumanCorporateInnovationResearch and development
Sales of antibiotics for use in food-producing animals drop across the EU 15 October 2018NewsVeterinaryAntimicrobial resistance
EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU 15 October 2018Press releaseHumanReferrals
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2018 12 October 2018Press releaseVeterinaryMedicines